ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010